The effectiveness of digital tools in improving the health of the elderly

The Effectiveness of Using Digital Health and Physical Activity Monitoring Tools on Health Indicators and Treatment Adherence in Older Adults: A Randomized Controlled Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251102067858N2

Enrollment

Registered

2025-12-09

Start date

2025-12-22

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hypertension. Condition 2: Diabetes. Essential (primary) hypertension Diabetes mellitus due to underlying condition

Interventions

Intervention 1: The intervention includes a “digital elderly monitoring package” consisting of a TCHZ10 smartwatch capable of measuring steps, hourly activity, heart rate, and data transmission to a d

the app is activated with a participant-specific user account, daily status dashboard, educational messages, and the ability to automatically send data to a secure research server. The intervention wi

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: Elderly people over 60 years of age visiting family health centers Being literate or having a home caregiver

Exclusion criteria

Exclusion criteria: Non-cooperation Severe cognitive problems

Design outcomes

Primary

Measure	Time frame
Using tools. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Questionnaire (yes/no).	—

Secondary

Measure	Time frame
Fasting Blood Sugar. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Glucometer.;Systolic and diastolic blood pressure. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Digital blood pressure monitor.;Medication adherence. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Score from the MMAS-8 questionnaire.;Satisfaction with technology. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Average scores on the TAM (Technology Acceptance Model) questionnaire.	—

Measure

Time frame

Fasting Blood Sugar. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Glucometer.;Systolic and diastolic blood pressure. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Digital blood pressure monitor.;Medication adherence. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Score from the MMAS-8 questionnaire.;Satisfaction with technology. Timepoint: At the beginning of the study and 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks and 12 weeks after the start of the intervention (use of the bracelet/smartwatch). Method of measurement: Average scores on the TAM (Technology Acceptance Model) questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Moradi Shahpar

Tehran University of Medical Sciences

f_moradishahpar@sbu.ac.ir+98 21 8863 0228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026